IRadimed Corporation

NASDAQ:IRMD

Medical - Devices

Healthcare
$82.31 +0.73%

+$0.67 today

Market cap
$1.05B
Beta
0.92
P/E (TTM)
49.7
EPS (TTM)
$1.85
Dividend yield
1.35%
52W Low $55.11High $107.90

Volume 0.08M

Average 0.12M

IRMD Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

IRadimed CorporationNASDAQ: IRMD

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin holds steady near 76.5%

Gross margin was 76.5% in Q1 FY2026, up 0.4 pp from a year earlier. On a trailing-twelve-month basis it was 76.8%, down 0.1 pp year over year. Over 3 fiscal years it narrowed by 0.7 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
76.5%+1.4 pp QoQ
Last fiscal yearDec 2025
76.7%-0.2 pp YoY
LTMMar 2026
76.8%-0.1 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.4 pp——
1 year-0.2 pp——
3 years-0.7 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
76.7%
Year-over-year change
-0.2pp

Gross Margin vs competitors

How IRMD compares with its peers on the latest reported figures

  • IRMD's LTM Mar 2026 gross margin of 76.8% is the 4th highest of the 11 companies compared; the peer median is 58.0%.
  • Its year-over-year change of -0.1 pp is the 4th highest of 11, against a peer median of -0.7 pp.
  • Over three fiscal years its change of -0.7 pp compares with a peer median of -1.8 pp.
IRMD Competitors Peer median
Gross Margin for IRMD and competitors
Company Period LTM level YoY 3-year change
GDRXGoodRx Holdings, Inc.LTM Mar 202686.6% -7.3 pp+1.3 pp
MDXGMiMedx Group, Inc.LTM Mar 202681.0% -0.8 pp+0.6 pp
INMDInMode Ltd.LTM Mar 202677.8% -2.2 pp-5.3 pp
IRMDIRadimed CorporationLTM Mar 202676.8% -0.1 pp-0.7 pp
AXGNAxoGen, Inc.LTM Sep 202674.2% -0.6 pp-4.2 pp
CTEVClaritev CorporationLTM Mar 202661.1% -13.1 pp-53.5 pp
TNDMTandem Diabetes Care, Inc.LTM Mar 202654.9% +8.4 pp+0.8 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 202653.2% -0.3 pp-10.6 pp
CRONCronos Group Inc.LTM Mar 202632.8% +5.2 pp+23.6 pp
OPKOPKO Health, Inc.LTM Mar 202622.7% -6.2 pp-7.6 pp
AHCOAdaptHealth Corp.LTM Apr 20265.4% +0.6 pp+3.5 pp
Peer median (excluding IRMD) 58.0%-0.7 pp-1.8 pp

Competitors are the stored peer set for IRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue41.81M53.3M65.56M73.24M83.81M
Cost of Revenue9.76M12.02M15.4M16.89M19.49M
Gross Profit32.05M41.28M50.16M56.35M64.32M
Gross Margin76.6%77.4%76.5%76.9%76.7%
Research & Development1.91M2.28M2.86M2.83M2.98M
Selling, General & Admin20.33M23.38M27.26M31.55M35.2M
Operating Expenses22.23M25.65M30.12M34.39M38.18M
Depreciation & Amortization1.41M670.67K765.18K817.66K2.38M
EBITDA11.24M16.85M22.5M25.09M30.74M
EBITDA Margin26.9%31.6%34.3%34.3%36.7%
Operating Income9.82M15.63M20.04M21.96M26.15M
Operating Margin23.5%29.3%30.6%30.0%31.2%
Interest Income34.81K581.85K1.86M2.19M0
Interest Expense00000
Other Income / Expenses18.61K553.1K1.7M2.31M2.21M
Income Before Tax9.84M16.18M21.74M24.28M28.36M
Pre-Tax Margin23.5%30.4%33.2%33.1%33.8%
Income Tax Expense510.82K3.35M4.55M5.04M5.88M
Net Income9.33M12.83M17.19M19.23M22.48M
Net Margin22.3%24.1%26.2%26.3%26.8%
EPS (Basic)0.761.021.361.521.77
EPS (Diluted)0.741.021.351.501.75
Weighted Avg Shares12.35M12.56M12.6M12.67M12.72M
Weighted Avg Shares (Diluted)12.59M12.64M12.72M12.78M12.85M

IRadimed Corporation

NASDAQ:IRMD

Intrinsic Alpha fair value

Locked

Current Price

$82.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.